Tim Oqueka Selected Research

Tim Oqueka Research Topics

3	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 01/2017
3	Emphysema 01/2018 - 12/2016
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 09/2023
1	Nasal Polyps (Nasal Polyp) 04/2023
1	Rhinosinusitis 04/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Dermatomyositis (Dermatopolymyositis) 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Post-Acute COVID-19 Syndrome 04/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Pulmonary Hypertension 01/2022
1	COVID-19 11/2021
1	Human Influenza (Influenza) 11/2021
1	Adenocarcinoma of Lung 12/2020
1	Pulmonary Arterial Hypertension 11/2020
1	Idiopathic Pulmonary Fibrosis 01/2020
1	Hemorrhage 12/2016
1	Hemoptysis 12/2016
1	Familial Primary Pulmonary Hypertension 10/2015
1	Filarial Elephantiasis (Lymphatic Filariasis) 07/2005

2	daratumumabIBA 09/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2020
1	dupilumabIBA 04/2023
1	Proteins (Proteins, Gene)FDA Link 04/2023
1	Immunoglobulin E (IgE)IBA 04/2023
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2023
1	SteroidsIBA 01/2023
1	tofacitinibIBA 01/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023
1	TransferasesIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Oxygen (Dioxygen)IBA 11/2021
1	Carbon DioxideIBA 11/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2016
1	Interleukin-17 (Interleukin 17)IBA 10/2015
1	Albendazole (Albenza)FDA Link 07/2005

6	Therapeutics 09/2023 - 01/2020
3	Pneumonectomy (Lung Volume Reduction) 01/2018 - 12/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2018
1	Length of Stay 12/2016
1	Mass Drug Administration 07/2005